- Home
- CMC vs IRTC Comparison
CMC vs IRTC Comparison
Compare CMC & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMC
- IRTC
- Stock Information
- Founded
- CMC 1915
- IRTC 2006
- Country
- CMC United States
- IRTC United States
- Employees
- CMC N/A
- IRTC N/A
- Industry
- CMC Steel/Iron Ore
- IRTC Medical/Dental Instruments
- Sector
- CMC Industrials
- IRTC Health Care
- Exchange
- CMC Nasdaq
- IRTC Nasdaq
- Market Cap
- CMC 5.5B
- IRTC 4.9B
- IPO Year
- CMC 1987
- IRTC 2016
- Fundamental
- Price
- CMC $52.13
- IRTC $135.30
- Analyst Decision
- CMC Buy
- IRTC Strong Buy
- Analyst Count
- CMC 7
- IRTC 10
- Target Price
- CMC $58.42
- IRTC $138.60
- AVG Volume (30 Days)
- CMC 1.1M
- IRTC 446.8K
- Earning Date
- CMC 06-23-2025
- IRTC 07-31-2025
- Dividend Yield
- CMC 1.38%
- IRTC N/A
- EPS Growth
- CMC N/A
- IRTC N/A
- EPS
- CMC 0.32
- IRTC N/A
- Revenue
- CMC $7,680,111,000.00
- IRTC $618,587,000.00
- Revenue This Year
- CMC N/A
- IRTC $19.91
- Revenue Next Year
- CMC $8.14
- IRTC $16.81
- P/E Ratio
- CMC $165.14
- IRTC N/A
- Revenue Growth
- CMC N/A
- IRTC 20.54
- 52 Week Low
- CMC $37.92
- IRTC $55.92
- 52 Week High
- CMC $64.53
- IRTC $157.13
- Technical
- Relative Strength Index (RSI)
- CMC 60.28
- IRTC 39.17
- Support Level
- CMC $50.91
- IRTC $129.48
- Resistance Level
- CMC $53.59
- IRTC $143.83
- Average True Range (ATR)
- CMC 1.30
- IRTC 5.16
- MACD
- CMC 0.16
- IRTC -2.35
- Stochastic Oscillator
- CMC 77.64
- IRTC 22.86
About CMC Commercial Metals Company
Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.